Press Releases

Etaluma, Inc. has partnered with Bulldog Bio to market, sell and support their novel suite of microscope systems. Their first model, the LumaScope 500, is an inverted fluorescence microscope that offers portability, environmental stability and affordability. This multi-year contract allows Bulldog Bio to be the face for this new product line in the USA.

“We are lucky to have garnered the LumaScope because of its nice complementation with our existing line of cell analysis instruments and reagents. This system has been tested in the jungles of Central America and is ideally suited for use directly in cell culture incubators. This will allow researchers the ability to automatically image cells as they grow or migrate in an unperturbed state –without the need of special flasks or plates. And at under $6,000, it should be attractive to many researchers during this period of funding contraction.” concludes Ella Fontaine, Vice President of Communications.

Etluma Inc. is a private company based in Carlsbad, CA that is dedicated to the design and manufacture of next generation imaging systems.

Bulldog Bio Incorporated is a privately held company headquartered in Portsmouth NH USA that distributes tools to Life Science researchers. Please visit www.bulldog-bio.com for more information about the company and its products.

Nepa Gene CO., LTD.,  an innovator of electropration devices and Bulldog Bio Inc., a specialty Life Science distributor, have signed an agreement to establish Bulldog Bio as the sole distributor of the new NEPA21 Electro-kinetic Transfection System to laboratories in the US and Canada.  Capable of using off-the-shelf electroporation cuvettes, this device can boost efficiency and reduce cytotoxicity for in vitro transfection experiments – and without the need for expensive proprietary buffers.  Also, with over 100 electrode options for in vivo, ex vivo, in ovo and in situ applications, transfection of living tissues is possible.

“This patented, one-of-a-kind system has transformed what an electroporator is capable of doing. It creates complex and dynamic electrical fields in a wide variety of matrices, and has opened the vistas for electro-mediated transfection.  And though we have had to wait almost 6 months while the infrastructure in Japan recovered from the natural disasters earlier this year, component suppliers are back online and the NEPA21 is now being produced on a predictable schedule.” Ella Fontaine, Vice President of Communications, elaborates “We are quite excited as this technology is already proven and has been used by researchers in Japan for a wide variety of non-in vitro application, from highly localized transfections in brain tissue, to general transfection of embryos, the possibilities are quite vast.”

Nepa Gene CO., LTD. is a private company based in the prefecture of Chiba, Japan, and a producer and supplier of electroporation, electro-cell fusion and sonoporation equipment.  With more than 30 years experience, Nepa Gene has become a leader in designing, implementing and supporting high quality instruments for the life science industry.

Bulldog Bio Incorporated is a privately held company headquartered in Portsmouth NH USA, that distributes tools to Life Science researchers located in the USA.  Please visit www.bulldog-bio.com for more information about the company and its products.

Eppendorf AG has licensed patents covering gradient technology for thermal cyclers to Bulldog Bio Inc. This worldwide license covers the popular GenePro and LifePro gradient thermal cycler models sold by Bulldog Bio. “We have made an investment into our growing PCR tools business.” Ella Fontaine, VP of Communications further elaborates, “This is part of our strategy to aggressively build the presence of Bulldog Bio in the PCR market.” 

Eppendorf AG, based in Hamburg, Germany, develops, produces and distributes instruments and consumables for the Life Science research industry. Additional information is available at: http://www.eppendorf.com

Bulldog Bio Incorporated is a privately held company headquartered in Portsmouth NH USA that distributes tools to Life Science researchers located in the USA. Please visit http://www.bulldog-bio.com for more information about the company and its products.

Bulldog Bio Inc. and Acqua Science Ltd. have agreed to a multi-year partnership allowing Bulldog Bio to exclusively represent Acqua Science’s new line of protein analytical tools.  Acqua Science has recently launched an eco-friendly protein gel stain that requires no pre- or post-gel processing and works in a fraction of the time of conventional Coomassie staining techniques. 

“Acqua Science products will nicely complement our growing portfolio of reagents and tools for protein analysis. Their first product, Acqua Stain, hits a sweet spot for the research market offering ease of use with time and cost savings.” Ella Fontaine, VP of Communications at Bulldog expounds, “We are happy to bring on board another exclusive supplier and will look to dedicate our resources to educate the research community on their innovative products.”

Dualsystems Biotech, a leading developer of protein-interaction discovery tools, and Bulldog Bio, a marketing-based US distributor, have agreed to a long-term relationship to sell Dualsystems’ extensive line of protein expression and analysis systems. The partnership will establish Bulldog Bio as the single source for all of Dualsystem’s products in the US.

“Dualsystems Biotech is the world leader in yeast two-hybrid screening with tools to analyze most classes of proteins in a living cell milieu. We are very excited to broaden the awareness and expand the use of their elegant systems for identifying de novo targets for proteins of interests. Their products allow effective screening of expressed cDNA libraries to detect specific interactors of nuclear, membrane and cytosolic proteins,” says Ella Fontaine, V.P. of Communications for Bulldog Bio. She further elaborates “We feel these technologies allow scientists and R&D teams to answer important, yet difficult questions in proteomics and cell function. It will be our job to communicate and support the many uses of these technologies.”

iNtRON Biotechnology has signed a long-term distribution and marketing agreement with Bulldog Bio to promote, stock and support their broad range of products within the US life science and molecular diagnostics markets. Bulldog Bio specializes in building brand awareness and market share for novel products from young companies in Europe in Asia. iNtRON Biotechnology is a well established company based in Seoul with a large portfolio of patents and products in the areas of nucleic acid purification and analysis, protein analysis and pathogen detection for non-clinical uses.

Ella Fontaine, VP of Communications at Bulldog states, “We see iNtRON as an integral piece in building our presence in the industrial, food and veterinary diagnostics markets. Their breadth of products and convenient formats will match our complementary line of instrumentation. Because of their large number of products, our plan is to stage their release throughout 2011 so as to maximize impact and the message to the research and business communities.”

Bulldog Bio has agreed to distribute cell analysis products from Digital Bio Technology Company, Ltd. to laboratories in the US and Canada. The agreement will have Bulldog Bio perform sales, logistics and technical support for the JuLi Smart Fluorescent Cell Analyzer, the C-Chip Disposable Hemocytometer and the family of ADAM Automated Cell Counters. Digital Bio is a wholly owned subsidiary of NanoEnTek, a publicly traded company on the Korean Stock Exchange whose core products are sold to the Life Science market under multiple brand names throughout the world.

“We feel fortunate to add such an exciting array of products for cell imaging and cell counting applications to our growing catalog.” Ella Fontaine, VP of Communications further relates “These Digital Bio products have a well conceived design with extremely affordable pricing that we feel the researchers in North America will respond favorably to.”

Bioer Ltd. and Bulldog Bio Inc. have agreed to jointly market Bioer’s complete line of PCR and general laboratory equipment to US researchers.  This agreement establishes Bulldog Bio as the exclusive distributor for these products in the USA with responsibilities to market, sell, and support Bioer’s extensive line of reagents and instruments.  “The managers at Bulldog Bio have promoted products for PCR for more than 15 years, and we are very excited to introduce Bioer’s tools here.  Bioer has a successful track record in Europe and Asia, and has developed a broad range of products that are affordable and robust with great performance to boot.”  Ella Fontaine, VP of Communications, continues: “We think the research community will respond quite favorably to this PCR line up and quickly realize value every day at the lab bench.”

Picodrop Ltd., developer of microliter-scale spectrophotometers, agrees to partner with Bulldog Bio for the promotion, sales and support of their innovative line of Picodrop-brand spectrophotometers for the US market.

“It’s hard to express how excited we are to present the Picodrop to researchers throughout the US” relates Ella Fontaine, VP of communications. “This product line offers a fresh perspective to the, relatively new, microliter spectrophotometer market. And we look forward to applying our tool chest of marketing solutions to raise the brand profile for this exquisite instrument.”

Genovis AB, developer and manufacturer of tools for transfection and antibody-engineering, has agreed to a one-year marketing collaboration with its US distributor – Bulldog Bio Inc. The agreement broadens an existing arrangement allowing for more extensive branding of Genovis’ products through marketing-based channels.

Ella Fontaine, Vice President of Communications at Bulldog Bio stated, “The innovative products provided by Genovis have an elegant story that will resonate with the US research community. We are pleased with the response to our unique, cost-sharing model, for marketing – and we look forward to advancing the awareness of Genovis’ brand here in the US.”

Bridge Bioscience Inc. has completed the transfer of all assets and intellectual property associated with the business to Bulldog Bio Incorporated. Bridge Bioscience has been manufacturing and providing high quality electroporation cuvettes for over eight years. These disposables are used for the delivery of DNA and RNA into a variety of eukaryotic and prokaryotic cells. With this purchase Bulldog Bio will complement their existing lines of transfection products and establish a manufacturing base for the company.

Ella Fontaine, Vice President of Communications at Bulldog Bio stated “The business model developed by Bridge of offering direct from manufacturer pricing, will allow Bulldog Bio to continue to provide these quality products at a very affordable level.” She further remarked “Bridge Bioscience has always run as a profitable business and it is our intent to maintain the current sales channel. We will look to develop growth in new markets in which the Bridge Electroporation Cuvettes are currently not being sold.”

Q.Instruments GmbH has offered its best selling line of mixing and incubation equipment, the BioShake series, to Bulldog Bio Inc. for distribution in the US. The partnership will provide Q.Instruments with a strong sales channel to deliver its patented lines of plate shakers and thermomixers to the US research community. Q.Instruments has already established the BioShake as a strong competitor in Europe, and is now looking to establish its brand in the US. Ella Fontaine, Vice President of Communications at Bulldog Bio stated: “This is another feather in our cap, as Bulldog looks to add compelling products that can generate excitement amongst researchers in the US. We look forward to using our extensive set of marketing tools to raise the brand awareness of the BioShake line.”

Genovis provides novel technical solutions for Transfection, RNAi, Imaging and Antibody Engineering for customers involved in sophisticated research in the pharmaceutical industry and academic research community.

For two years the fully owned subsidiary Genovis Inc. has consistently built sales channels in the US. During this period several distribution agreements have been entered, and Genovis has thus decided to close down its subsidiary and to work only through distributors and collaborators in the US market.

”This distribution agreement is an important step for Genovis as we expand into the North American market. The agreement broadens our presence and increases the exposure of our trademark. I am pleased with the opportunities this represents and I look forward to working with Bulldog Bio and their efficient and experienced team”, says Sarah Fredriksson, CEO Genovis AB.

Bulldog Bio is committed to growing the market share and revenue of its partners’ product lines in the US Life Science research community. Brand building, technical expertise and world-class support are the foundation of Bulldog Bio’s business model. The company employees have broad competence in Genovis’ business areas and pride themselves on efficient service and effective marketing.

Bulldog Bio Inc. and Medline Inc. agree to an alliance for bringing Medline's flagship line of Labcare products to the life science market place. Bulldog Bio will market and sell Aloetouch and Remedy branded lines directly to the research community. "It is our belief that these lines will offer the pinnacle for improving the personal satisfaction of any bench researcher. We are surprised that these market-leading products haven't already made their way into research laboratories. And we feel fortunate to be the first to offer them to US scientific community."